Alere completes sale of BBI business to Exponent Private Equity

Alere Inc. (NYSE: ALR), a global leader in rapid diagnostics announced today the completion of the previously announced sale of its BBI business to Exponent Private Equity LLP, a UK-based private equity firm. BBI Group provides products and services for the diagnostic, healthcare, research, defense and food industries globally.

The total purchase price was $115 million, based on foreign exchange rates as of Nov, 17, 2015. Alere is eligible to receive up to an additional $47 million in contingent consideration.

Alere intends to use all of the proceeds to pay down existing indebtedness.

Source:

Alere Inc.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Alere Inc.. (2019, June 20). Alere completes sale of BBI business to Exponent Private Equity. News-Medical. Retrieved on June 27, 2019 from https://www.news-medical.net/news/20151119/Alere-completes-sale-of-BBI-business-to-Exponent-Private-Equity.aspx.

  • MLA

    Alere Inc.. "Alere completes sale of BBI business to Exponent Private Equity". News-Medical. 27 June 2019. <https://www.news-medical.net/news/20151119/Alere-completes-sale-of-BBI-business-to-Exponent-Private-Equity.aspx>.

  • Chicago

    Alere Inc.. "Alere completes sale of BBI business to Exponent Private Equity". News-Medical. https://www.news-medical.net/news/20151119/Alere-completes-sale-of-BBI-business-to-Exponent-Private-Equity.aspx. (accessed June 27, 2019).

  • Harvard

    Alere Inc.. 2019. Alere completes sale of BBI business to Exponent Private Equity. News-Medical, viewed 27 June 2019, https://www.news-medical.net/news/20151119/Alere-completes-sale-of-BBI-business-to-Exponent-Private-Equity.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post
You might also like... ×
Alere announces cash dividend of $3.00 per share on its Series B Convertible Perpetual Preferred Stock